Title of article :
Structure–activity relationship of Aza-steroids as PI-PLC inhibitors Original Research Article
Author/Authors :
Wenge Xie، نويسنده , , Hairuo Peng، نويسنده , , Deog-Il Kim، نويسنده , , Mark Kunkel، نويسنده , , Garth Powis and William R Montfort، نويسنده , , Leon H. Zalkow، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2001
Pages :
11
From page :
1073
To page :
1083
Abstract :
A number of aza-steroids were synthesized as potent phosphatidylinositol phospholipase C (PI-PLC) inhibitors. The epimeric mixtures 22,25-diazacholesterol (8a) and 3β-hydroxy-22,25-diazacholestane (8b) were among the most active of these inhibitors, with IC50 values of 7.4 and 7.5 μM, respectively. The 20α epimer, 8a2 (IC50=0.64 μM), whose stereochemistry at C-20 coincides with that of cholesterol, was found 50 times more potent than the 20β epimer, 8a1 (IC50=32.2 μM). In diaza-estrone derivatives, the 3-methoxy group on the aromatic A-ring of 23 exhibited moderate PI-PLC inhibitory activity (IC50=19.7 μM), while compound with a free hydroxyl group (21) was inactive. However, in diaza-pregnane derivatives, epimers with a 3-hydroxyl group (8a, IC50=7.4 μM) exhibited more potent PI-PLC inhibitory activity than their counterparts with 3-methoxyl group on the non-aromatic A-ring (26, IC50=17.4 μM). We have illustrated in our previous publication that 3-hydroxyl-6-aza steroids are potent PI-PLC inhibitors.3 However, simultaneous presence of the 6-aza and 22,25-diaza moieties in one molecule as in 13, led to loss of activity. Epimeric mixture 8a showed selective growth inhibition effects in the NCI in vitro tumor cell screen with a mean GI50 value (MG-MID) of 5.75 μM for 54 tumors.
Journal title :
Bioorganic and Medicinal Chemistry
Serial Year :
2001
Journal title :
Bioorganic and Medicinal Chemistry
Record number :
1301498
Link To Document :
بازگشت